Cost-effectiveness and dynamic efficiency: does the solution lie within?
File(s)
Author(s)
Camejo, RR
Miraldo, M
Rutten, F
Type
Journal Article
Abstract
The majority of the current systems spread across the world require the demonstration of the value of pharmaceuticals to be done with an acceptable degree of certainty before a technology is funded. Often involving the notion of cost-effectiveness, one of the key characteristic of such assessments tends to be the consideration of efficiency as a static outcome; with a strong emphasis on current health gains but a disregard of the impact of decision making on the potential health value over time. In this manuscript we argue that current systems using cost-effectiveness thresholds may provide an incomplete indicator of value and defend that funding decisions should be informed by dynamic efficiency considerations by considering both the current and the future value of achieving a certain level of effectiveness in a disease area. We further lay down the foundations for the implementation such framework.
Date Issued
2017-02-24
Date Acceptance
2016-11-30
Citation
Value in Health, 2017, 20 (2), pp.240-243
ISSN
1524-4733
Publisher
Elsevier
Start Page
240
End Page
243
Journal / Book Title
Value in Health
Volume
20
Issue
2
Copyright Statement
© 2017, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Outcomes Research (ISPOR). Published by Elsevier Inc. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Subjects
cost-effectiveness
dynamic efficiency
pharmaceutical innovation
value framework
Health Policy & Services
1117 Public Health And Health Services
1402 Applied Economics
Publication Status
Published